IOVERSOL — all Canadian products
10 DINs
1 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is IOVERSOL, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02387441 | OPTIRAY 300 (ULTRAJECT) | LIEBEL-FLARSHEIM COMPANY LLC | Solution | Intravascular | IOVERSOL 64 % | Approved | |
| 01900838 | OPTIRAY 160 | TYCO HEALTHCARE | Solution | Intravenous | IOVERSOL 34 % | Cancelled Post Market | |
| 02035618 | OPTIRAY 160 (ULTRAJECT) | TYCO HEALTHCARE | Solution | Intravascular | IOVERSOL 34 % | Cancelled Pre Market | |
| 02225263 | OPTIRAY 240 | LIEBEL-FLARSHEIM COMPANY LLC | Solution | Subarachnoidal; Intravascular | IOVERSOL 51 % | Cancelled Post Market | |
| 02035332 | OPTIRAY 240 (ULTRAJECT) | LIEBEL-FLARSHEIM COMPANY LLC | Solution | Intravascular; Subarachnoidal | IOVERSOL 51 % | Cancelled Post Market | |
| 02034492 | OPTIRAY 300 | LIEBEL-FLARSHEIM COMPANY LLC | Solution | Intravascular | IOVERSOL 64 % | Dormant | |
| 01900854 | OPTIRAY 320 | LIEBEL-FLARSHEIM COMPANY LLC | Solution | Intravascular | IOVERSOL 68 % | Dormant | |
| 02035626 | OPTIRAY 320 (ULTRAJECT) | LIEBEL-FLARSHEIM COMPANY LLC | Solution | Intravascular | IOVERSOL 68 % | Dormant | |
| 02034484 | OPTIRAY 350 | LIEBEL-FLARSHEIM COMPANY LLC | Solution | Intravascular | IOVERSOL 74 % | Dormant | |
| 02079992 | OPTIRAY 350 (ULTRAJECT) | LIEBEL-FLARSHEIM COMPANY LLC | Solution | Intravascular | IOVERSOL 74 % | Dormant |
Browse other molecules: